WA
PRCT icon

Wasatch Advisors’s Procept Biorobotics PRCT Stock Holding History

Wasatch Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-222,644
Closed -$5.57M – 232
2026
Q1 		$5.57M Buy
222,644
+232
+0.1% +$6.54K 0.04% 157
2025
Q4 		$7M Buy
222,412
+65,945
+42% +$2.19M 0.04% 157
2025
Q3 		$5.58M Sell
156,467
-32,219
-17% -$1.47M 0.03% 181
2025
Q2 		$10.9M Buy
188,686
+47,632
+34% +$2.69M 0.06% 152
2025
Q1 		$8.22M Buy
141,054
+98,672
+233% +$6.74M 0.05% 165
2024
Q4 		$3.41M Buy
+42,382
New +$3.62M 0.02% 202

Other funds holding PRCT

CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
FRA
Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
RAM
Robocap Asset Management London, United Kingdom $124M AUM 95% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
GITFIT
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) Warsaw, Poland $249M AUM 37.04% 1-Year Est. Return

Wasatch Advisors's PRCT Position: Q2 2026 in Review

Wasatch Advisors sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 222,644 shares — an estimated $5.57M sold.

Wasatch Advisors first reported a position in PRCT in Q4 2024 and held it in 6 quarters. The position peaked at $10.9M in Q2 2025. 52 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Wasatch Advisors reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Wasatch Advisors sold 222,644 Procept Biorobotics shares in Q2 2026, an estimated $5.57M.
  • Wasatch Advisors first reported a position in Procept Biorobotics in Q4 2024 and held it in 6 quarters.
  • Wasatch Advisors's Procept Biorobotics position peaked at $10.9M in Q2 2025.
  • 52 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.